Catalyst Wire Dossier Catalyst Wire Dossier

Rebamipide ophthalmic solution

rebamipide · Kubota Vision Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rebamipide ophthalmic solution, covering 2014-05-07 to 2014-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome [Phase 3]

See pricing